Stuart Ince brings over 19 years of experience, primarily in oncology, to Tango Therapeutics as the Head of Program Management. Prior to joining Tango, Stuart oversaw global development programs at Bayer in both early and late clinical phases, and most recently, registration. Prior to that, he led discovery programs as a medicinal chemist at both Bayer and Schering AG.
Stuart graduated from Cambridge University with a Bachelor of Arts in Natural Sciences, majoring in Chemistry. He stayed at Cambridge for his doctorate before moving to the RWTH in Aachen, Germany, as a Marie Curie Research Fellow.